Brain mapping of patients with lung cancer and controls: Inquiry into tumor-to-brain communication

Journal of Nuclear Medicine

Volumn 50, Issue 7, 2009, Pages 1072-1075

  Golan, Haim ^a   Kennedy, John A ^b   Frenkel, Alex ^b   Parmet, Ysrael ^c   Feintuch, Akiva ^c   Levi, Ofer ^c   Gidron, Yori ^d  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Fdg brain pet; Lung cancer; Tumorto brain communication; Vagus nerve

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IMMUNOREGULATION; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOLITARY TRACT NUCLEUS; VAGUS NERVE;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; CELL COMMUNICATION; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 67650085303     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.061085     Document Type: Article

References (20)

1. Mbeunkui F, Johann DJ Jr. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol. 2009;63:571-582.
2. Gidron Y, Perry H, Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol. 2005;6:245-248.
3. Pikarsky E, Porat RM, Stein I, et al. NF-kappa B functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461-466.
4. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285-296.
5. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA. 2003;100:2645-2650.
6. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 1998;18:9471-9479.
7. Ekbom A, Lundegårdh G, McLaughlin JK, Nyrén O. Relation of vagotomy to subsequent risk of lung cancer: population based cohort study. BMJ. 1998;316:518-519.
8. Lundegårdh G, Ekbom A, McLaughlin JK, Nyrén O. Gastric cancer risk after vagotomy. Gut. 1994;35:946-949.
9. Bernstein IL. Neutral mediation of food aversions and anorexia induced by tumor necrosis factor and tumors. Neurosci Biobehav Rev. 1996;20:177-181.
10. Erin N, Barkan GA, Harms JF, Clawson GA. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters Substance P level. Regul Pept. 2008;151:35-42.
11. Mravec B, Gidron Y, Kukanova B, Bizik J, Kiss A, Hulin I. Neural-endocrineimmune complex in the central modulation of tumorigenesis: facts, assumptions, and hypotheses. J Neuroimmunol. 2006;180:104-116.
12. Tashiro M, Itoh M, Kubota K, et al. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Psychooncology. 2001;10:541-546.
13. Tashiro M, Juengling FD, Reinhardt MJ, et al. Reproducibility of PET brain mapping of cancer patients. Psychooncology. 2000;9:157-163.
14. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients: evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005;12:279-287.
15. Silverman DHS, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007;103:303-311.
16. Turrin NP, Gayle D, Ilyin SE, et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull. 2001;54:443-453.
17. Darnell RB. Paraneoplastic syndromes. In: Current Diagnosis in Neurology. Feldmann E, ed. St. Louis, MO: Mosby-Year Book, Inc.; 1994:137-141.
18. Zhu JN, Yung WH, Kwok-Chong Chow B, Chan YS, Wang JJ. The cerebellar-hypothalamic circuits: potential pathways underlying cerebellar involvement in somatic-visceral integration. Brain Res Rev. 2006;52:93-106.
19. Onat F, Cavdar S. Cerebellar connections: hypothalamus. Cerebellum. 2003;2:263-269.
20. Meador KJ, Loring DW, Ray PG, Helman SW, Vazquez BR, Neveu PJ. Role of cerebral lateralization in control of immune processes in humans. Ann Neurol. 2004;55:840-844.